Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Effect of Treatment With Finerenone on Cardio-Renal Target Organ Damage in Patients With Type 2 Diabetes - A Randomized Trial

NCT07026539 is registered in ClinicalTrials.gov with University of Aarhus as lead sponsor.

NCT NCT07026539
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07026539 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Effect of Treatment With Finerenone on Cardio-Renal Target Organ Damage in Patients With Type 2 Diabetes - A Randomized Trial
Lead sponsor
University of Aarhus
Phase
Phase 4
Overall status
Recruiting
Start date
October 23, 2024
Completion date
April 30, 2028
Enrollment
80 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

cardiovascular diseases, chronic kidney disease due to type 2 diabetes mellitus, type 2 diabetes mellitus (t2dm)